CASTRES, France, September 1, 2010 /PRNewswire/ -- During its first meeting, the Board of Directors of Pierre Fabre SA chaired by Mr. Pierre Fabre appointed Olivier BOHUON as the company's Chief Executive Officer.
Olivier BOHUON, 51, has until now been the executive vice-president of Abbott Corporation and president of its pharmaceutics division. In this capacity, he directed the group's entire pharmaceutical business (22 billion dollars turnover) from Chicago. He also became group president for Europe in 2003 and subsequently president of Abbott international.
Olivier BOHUON has also been appointed president of Pierre Fabre Médicament as of today.
About the Pierre Fabre group
The Pierre Fabre group, owned on a majority basis by a public utility Foundation, is France's second largest independent pharmaceutics laboratory and the leader in cosmetics products sold in pharmacies.
It employs a workforce of nearly 10,000 including 1,400 in research.
In 2009, the Pierre Fabre group achieved a turnover of 1.8 billion EUR and dedicated 28% of its medical turnover to research and development in three main therapeutic areas: oncology, central nervous system, dermatology and cardio-vascular/metabolism.
To find out more about Laboratoires Pierre Fabre : http://www.pierre-fabre.com
SOURCE: Groupe Pierre Fabre
CONTACT: Press contacts: Djamila Hazene-Kedjem: +33(0)1-49-10-81-12,+33(0)6-89-45-87-95,firstname.lastname@example.org